EA201301355A1 - Композиция и таблетка, содержащая ралтегравир - Google Patents

Композиция и таблетка, содержащая ралтегравир

Info

Publication number
EA201301355A1
EA201301355A1 EA201301355A EA201301355A EA201301355A1 EA 201301355 A1 EA201301355 A1 EA 201301355A1 EA 201301355 A EA201301355 A EA 201301355A EA 201301355 A EA201301355 A EA 201301355A EA 201301355 A1 EA201301355 A1 EA 201301355A1
Authority
EA
Eurasian Patent Office
Prior art keywords
composition
tablet containing
raltegravir
containing raltegravir
tablet
Prior art date
Application number
EA201301355A
Other languages
English (en)
Inventor
Даниела Штумм
Доминик Мерганс
Original Assignee
Рациофарм Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Рациофарм Гмбх filed Critical Рациофарм Гмбх
Publication of EA201301355A1 publication Critical patent/EA201301355A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

В заявке описаны композиция и таблетка, содержащая ралтегравир, и способ изготовления такой таблетки.
EA201301355A 2011-06-01 2012-05-29 Композиция и таблетка, содержащая ралтегравир EA201301355A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11168543.4A EP2529741B1 (en) 2011-06-01 2011-06-01 Composition and Tablet Comprising Raltegravir
PCT/EP2012/059991 WO2012163893A1 (en) 2011-06-01 2012-05-29 Composition and tablet comprising raltegravir

Publications (1)

Publication Number Publication Date
EA201301355A1 true EA201301355A1 (ru) 2014-05-30

Family

ID=44188025

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201301355A EA201301355A1 (ru) 2011-06-01 2012-05-29 Композиция и таблетка, содержащая ралтегравир

Country Status (7)

Country Link
US (1) US20140094478A1 (ru)
EP (2) EP2529741B1 (ru)
CA (1) CA2837241A1 (ru)
EA (1) EA201301355A1 (ru)
ES (1) ES2450944T3 (ru)
IL (1) IL229206A0 (ru)
WO (1) WO2012163893A1 (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2875024A4 (en) * 2012-07-20 2015-12-23 Merck Sharp & Dohme HIV TREATMENT WITH AMIDOSUBSTITUTED PYRIMIDINONE DERIVATIVES
WO2014064711A2 (en) * 2012-10-22 2014-05-01 Hetero Research Foundation Methods of administering raltegravir and raltegravir compositions
WO2021148992A1 (en) * 2020-01-23 2021-07-29 Lupin Limited Pharmaceutical compositions of raltegravir

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GEP20063848B (en) 2001-10-26 2006-06-12 Inst Di Richerche Di Biolog Moltcolare P Angeletti Spa N-substituted hydroxypyrimi-dinone carboxamide inhibitors of hiv integrase
MX2007006635A (es) * 2004-12-03 2007-06-19 Merck & Co Inc Formulacion farmaceutica de inhibidores dela carboxamida vih integrasa que contienen una composicion que controla la velocidad de liberacion.
UA87884C2 (ru) 2004-12-03 2009-08-25 Мерк Энд Ко., Инк. Безводная кристаллическая калиевая соль ингибитора вич-интегразы
WO2007087188A2 (en) * 2006-01-20 2007-08-02 Merck & Co., Inc. Taste-masked tablets and granules
WO2009079412A2 (en) * 2007-12-14 2009-06-25 Ardea Biosciences Inc. Reverse transcriptase inhibitors
ES2524380T3 (es) * 2010-04-01 2014-12-05 Teva Pharmaceutical Industries Ltd. Sales de raltegravir y formas cristalinas de las mismas
WO2012137142A1 (en) * 2011-04-06 2012-10-11 Lupin Limited Novel salts of raltegravir

Also Published As

Publication number Publication date
CA2837241A1 (en) 2012-12-06
US20140094478A1 (en) 2014-04-03
IL229206A0 (en) 2014-01-30
EP2529741B1 (en) 2014-02-12
ES2450944T3 (es) 2014-03-25
EP2529741A1 (en) 2012-12-05
EP2714044A1 (en) 2014-04-09
WO2012163893A1 (en) 2012-12-06

Similar Documents

Publication Publication Date Title
IN2012DN06714A (ru)
MX353579B (es) Organoide hepatico, sus usos y metodo de cultivo para obtenerlos.
BR112014030278A2 (pt) anticorpo, e, composição.
UY34765A (es) Compuestos novedosos.
UY34559A (es) Inhibidores de bromodominios
IT1403054B1 (it) Bottiglia.
DK2773633T3 (da) Heterocykliske forbindelser, medikamenter indeholdende forbindelserne, anvendelse deraf og fremgangsmåder til fremstilling deraf.
DK2741763T3 (da) Sammensætning til kontrolleret ovariestimulering.
MX370649B (es) Proceso para la preparacion de teneligliptina.
EA201490761A1 (ru) R(+)-n-формилпропаргиламиноиндан
EA201301090A1 (ru) Антидоты антикоагулянтов
BR112014032501A2 (pt) composto, e, composição farmacêutica.
EP3299025A4 (en) COMPOSITION WITH QUISQUALIS INDICA
EA201301355A1 (ru) Композиция и таблетка, содержащая ралтегравир
CL2012001192S1 (es) Botella.
EP3106453A4 (en) Method for producing optically active compound, and novel metal-diamine complex
BR112015013027A2 (pt) método de esmalte, composição e conjunto.
CL2011000028S1 (es) Envase dispensador
MX359800B (es) Método para la preparación de 2-alquil-1,2-benzisotiazolin-3-onas.
GB2491544A (en) Perpetum mobile
TH1301006508B (th) องค์ประกอบที่รวมถึงโพลีเตตระฟลูออโรเอธิลีน และกระบวนการสำหรับการเตรียมองค์ประกอบของสิ่งนั้น
CL2011000572S1 (es) Contenedor.
AU2012900413A0 (en) iLease.co (website & mobile app for self-property management)
CL2011001069S1 (es) Triciclo.
TN2011000372A1 (fr) جهاز مراقبة وتحكم في استهلاك المياه